BioSenic S.A.

    297 Aufrufe 297 0 Kommentare 0 Kommentare

    Transparency notification received from ABO Infinium Americas OpCo LTD.

      REGULATED INFORMATION
     Article 14 of the Law of 2 May 2007 on disclosure of major holdings

    Mont-Saint-Guibert, Belgium, August 13, 2024, 1.00pm CEST – BIOSENIC (Euronext Brussels and Paris: BIOS), the clinical-stage company specializing in serious autoimmune and inflammatory diseases and cell therapy, today announces that it has received a transparency notification from ABO Infinium Americas OpCo LTD. The details of the transparency notification are set out below and the full text of the transparency notification can be consulted on the website of BioSenic, under the heading “Major shareholders & transparency notices”.

    The transparency notification indicates that the voting rights attached to BioSenic's shares held by ABO Infinium Americas OpCo LTD. have crossed above the threshold of 5% as a result of the acquisition of shares of BioSenic.

    The notification received from ABO Infinium Americas OpCo LTD. dated 9 August 2024 contains the following information:

    • Reason for the notification: Acquisition or transfer of voting securities or voting rights
    • Notification by: A parent company or controlling person
    • Person subject to the notification requirement:
      • ABO Infinium Americas OpCo LTD.
      • ABO Securities
      • Omega Financial Corporation
      • Mr Pierre Vannineuse
    • Transaction date: 1st July 2024
    • Threshold that is crossed: 5%
    • Denominator: 251 312 817
    • Notified details:

    Voting rights Previous notification After the transaction
    Holders of voting rights # of voting rights # of voting rights % of voting rights
    Mr Pierre Vannineuse N/A 0 0.00%
    Omega Financial Corporation N/A 0 0.00%
    ABO Securities N/A 0 0.00%
    ABO Infinium Americas OpCo LTD. N/A 20 588 234 8.19%
    Total voting rights   20 588 234 8.19%
    • Full chain of controlled undertakings through which the holding is effectively held: ABO Infinium Americas OpCo LTD. (303 Shriley Street, Nassau, Bahamas) is 100% owned by ABO Securities (71 Fort Street, Georges Town, Grand Cayman, Cayman Island). ABO Securities is 100% owned by Omega Financial Corporation (71 Fort Street, Georges Town, Grand Cayman, Cayman Island). Omega Financial Corporation is 100% owned by Pierre Vannineuse.
    Seite 1 von 3



    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    BioSenic S.A. Transparency notification received from ABO Infinium Americas OpCo LTD.   REGULATED INFORMATION Article 14 of the Law of 2 May 2007 on disclosure of major holdings Mont-Saint-Guibert, Belgium, August 13, 2024, 1.00pm CEST – BIOSENIC (Euronext Brussels and Paris: BIOS), the clinical-stage company specializing in serious …